{"transactions":[{"id":1946432,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T21:00:07.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":50000,"price":23.0333,"value":1151665.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.7500 to $23.4300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1149069,"source":{"system":"sec-edgar","filing":"0001209191-23-019943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919123019943/doc4.xml","form_type":"4"}},{"id":2007040,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T17:52:00.000Z","date":"2023-02-16","kind":"gift","acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST"},"balance_after":361700,"source":{"system":"sec-edgar","filing":"0001209191-23-010852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919123010852/doc4.xml","form_type":"4"}},{"id":2007039,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T17:52:00.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":50000,"price":21.707,"value":1085350.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4800 to $22.1380 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1199069,"source":{"system":"sec-edgar","filing":"0001209191-23-010852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919123010852/doc4.xml","form_type":"4"}},{"id":2015637,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-14T21:00:28.000Z","date":"2022-11-11","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST"},"balance_after":370000,"source":{"system":"sec-edgar","filing":"0001209191-23-009582","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919123009582/doc5.xml","form_type":"5"}},{"id":2049514,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-20T21:00:12.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":50000,"price":25.88,"value":1294000.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5400 to $26.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1249069,"source":{"system":"sec-edgar","filing":"0001209191-23-004342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919123004342/doc4.xml","form_type":"4"}},{"id":2083489,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-16T21:00:12.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":50000,"price":23.9987,"value":1199935.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.4900 to $24.2400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1299069,"source":{"system":"sec-edgar","filing":"0001209191-22-061757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122061757/doc4.xml","form_type":"4"}},{"id":2106738,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:00:13.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":10070,"price":22.105,"value":222597.35,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.020 to $22.640 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1349069,"source":{"system":"sec-edgar","filing":"0001209191-22-058549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122058549/doc4.xml","form_type":"4"}},{"id":2106737,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:00:13.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":224,"price":22.084,"value":4946.816,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.010 to $22.180 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1359139,"source":{"system":"sec-edgar","filing":"0001209191-22-058549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122058549/doc4.xml","form_type":"4"}},{"id":2106736,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:00:13.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":2101,"price":23.455,"value":49278.955,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.250 to $23.610 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1359363,"source":{"system":"sec-edgar","filing":"0001209191-22-058549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122058549/doc4.xml","form_type":"4"}},{"id":2106735,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:00:13.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":37605,"price":22.659,"value":852091.695,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.250 to $23.230 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1361464,"source":{"system":"sec-edgar","filing":"0001209191-22-058549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122058549/doc4.xml","form_type":"4"}},{"id":2110123,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-18T20:00:28.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":50000,"price":20.138,"value":1006900.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.760 to $20.370 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1399069,"source":{"system":"sec-edgar","filing":"0001209191-22-058000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122058000/doc4.xml","form_type":"4"}},{"id":2181331,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:00:23.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":50000,"price":19.91,"value":995500.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.475 to $20.12 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1449069,"source":{"system":"sec-edgar","filing":"0001209191-22-046491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122046491/doc4.xml","form_type":"4"}},{"id":2193045,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-05T18:01:25.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":4904,"price":19.0401,"value":93372.6504,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.91 to $19.34 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1499069,"source":{"system":"sec-edgar","filing":"0001209191-22-044621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122044621/doc4.xml","form_type":"4"}},{"id":2193044,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-05T18:01:25.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":48217,"price":18.5562,"value":894724.2954,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.50 to $19.03 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1503973,"source":{"system":"sec-edgar","filing":"0001209191-22-044621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122044621/doc4.xml","form_type":"4"}},{"id":2193043,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-05T18:01:25.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":96879,"price":18.8469,"value":1825868.8251,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.50 to $19.17 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1552190,"source":{"system":"sec-edgar","filing":"0001209191-22-044621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000120919122044621/doc4.xml","form_type":"4"}},{"id":2263365,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-19T20:38:12.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":16625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":16625,"derivative":{"exercise_price":15.8,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":16625},"source":{"system":"sec-edgar","filing":"0001567619-22-011344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761922011344/doc1.xml","form_type":"4"}},{"id":2263364,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T20:38:12.000Z","date":"2022-05-09","kind":"gift","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST"},"balance_after":385000,"source":{"system":"sec-edgar","filing":"0001567619-22-011344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761922011344/doc1.xml","form_type":"4"}},{"id":2263363,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T20:38:12.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":2295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date."}],"balance_after":2295,"source":{"system":"sec-edgar","filing":"0001567619-22-011344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761922011344/doc1.xml","form_type":"4"}},{"id":2339554,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-10T20:22:34.000Z","date":"2022-01-13","kind":"gift","acquired":false,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST"},"balance_after":505000,"source":{"system":"sec-edgar","filing":"0001567619-22-006728","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761922006728/doc1.xml","form_type":"4"}},{"id":2401256,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T16:27:04.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST"},"balance_after":600000,"source":{"system":"sec-edgar","filing":"0001567619-22-003543","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761922003543/doc1.xml","form_type":"5"}},{"id":2401255,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T16:27:04.000Z","date":"2021-12-09","kind":"gift","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"balance_after":1649069,"source":{"system":"sec-edgar","filing":"0001567619-22-003543","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761922003543/doc1.xml","form_type":"5"}},{"id":2536226,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-22T21:35:03.000Z","date":"2021-10-20","kind":"sale","acquired":false,"shares":11171,"price":25.1763,"value":281244.4473,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25 to $25.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2249069,"source":{"system":"sec-edgar","filing":"0001567619-21-018626","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761921018626/doc1.xml","form_type":"4"}},{"id":2536225,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-22T21:35:03.000Z","date":"2021-09-07","kind":"gift","acquired":false,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Gifted to irrevocable trust with a third party trustee for the benefit of a different natural person."}],"balance_after":2260240,"source":{"system":"sec-edgar","filing":"0001567619-21-018626","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761921018626/doc1.xml","form_type":"4"}},{"id":2536224,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-22T21:35:03.000Z","date":"2021-09-07","kind":"gift","acquired":false,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Gifted to irrevocable trust with a third party trustee for the benefit of a natural person."}],"balance_after":2540240,"source":{"system":"sec-edgar","filing":"0001567619-21-018626","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000156761921018626/doc1.xml","form_type":"4"}},{"id":2735677,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:17:22.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":299509,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":299509},"source":{"system":"sec-edgar","filing":"0000899243-21-017480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000089924321017480/doc4.xml","form_type":"4"}},{"id":2735676,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:17:22.000Z","date":"2021-04-27","kind":"other","acquired":true,"shares":6931,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."}],"balance_after":299509,"derivative":{"underlying":"Common Stock","underlying_shares":6931},"source":{"system":"sec-edgar","filing":"0000899243-21-017480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000089924321017480/doc4.xml","form_type":"4"}},{"id":2735675,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T21:17:22.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":299509,"ownership":{"direct":false,"nature":"Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date"}],"balance_after":2820240,"source":{"system":"sec-edgar","filing":"0000899243-21-017480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000089924321017480/doc4.xml","form_type":"4"}},{"id":2739463,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":115413,"kind":"person","name":"TIMBIE THOMAS E","position":1,"cik":"0001188309","reported_name":"TIMBIE THOMAS E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy","published_at":"2021-04-26T21:06:04.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":21240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 substantially equal installments, commencing on May 22, 2021, such that the stock option will be fully vested and exercisable on April 22, 2022, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":21240,"derivative":{"exercise_price":17,"expiration_date":"2031-04-22","underlying":"Common Stock","underlying_shares":21240},"source":{"system":"sec-edgar","filing":"0000899243-21-017036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188309/000089924321017036/doc4.xml","form_type":"4"}}]}